Cargando…

New algorithm for OHSS prevention

Ovarian hyperstimulation syndrome (OHSS) still remains a life-threatening complication of in vitro fertilization treatment (IVF), keeping patients and especially those, who previously experienced OHSS, from attempting infertility treatment and childbearing. The recent implementation of four new moda...

Descripción completa

Detalles Bibliográficos
Autores principales: Papanikolaou, Evangelos G, Humaidan, Peter, Polyzos, Nikos, Kalantaridou, Sofia, Kol, Sahar, Benadiva, Claudio, Tournaye, Herman, Tarlatzis, Basil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230134/
https://www.ncbi.nlm.nih.gov/pubmed/22054506
http://dx.doi.org/10.1186/1477-7827-9-147
_version_ 1782218038895968256
author Papanikolaou, Evangelos G
Humaidan, Peter
Polyzos, Nikos
Kalantaridou, Sofia
Kol, Sahar
Benadiva, Claudio
Tournaye, Herman
Tarlatzis, Basil
author_facet Papanikolaou, Evangelos G
Humaidan, Peter
Polyzos, Nikos
Kalantaridou, Sofia
Kol, Sahar
Benadiva, Claudio
Tournaye, Herman
Tarlatzis, Basil
author_sort Papanikolaou, Evangelos G
collection PubMed
description Ovarian hyperstimulation syndrome (OHSS) still remains a life-threatening complication of in vitro fertilization treatment (IVF), keeping patients and especially those, who previously experienced OHSS, from attempting infertility treatment and childbearing. The recent implementation of four new modalities: the GnRH antagonist protocol, GnRH agonist (GnRHa) triggering of ovulation, blastocyst transfer and embryo/oocyte vitrification, renders feasible the elimination of OHSS in connection with ovarian hyperstimulation for IVF treatment. The proposed current algorithm is based on the number of follicles developed after ovarian stimulation, setting a cut-off level at the development of 18 or more follicles. Further, fulfilling this criterion, the algorithm is based on four decision-making points: the final day of patient work-up, the day of triggering final oocyte maturation, day-1 post oocyte pick-up (OPU) and day-5 post OPU. If the physician decides to administer hCG for final oocyte maturation regardless the type of analogue used, he has the option on day-1 to either freeze all embryos or to proceed to day-5. On this day, based on the clinical condition of the patient, a decision should be made to either transfer a single blastocyst or to vitrify all blastocysts available. However, this strategy will not guarantee an OHSS free luteal phase especially if a pregnancy occurs. If the physician decides to trigger ovulation with GnRHa, feasible only with the antagonist protocol, embryos can be cultured until day-5. On this day a transfer can be performed with no risk of OHSS and spare blastocysts may be vitrified. Alternatively, on day-1 or day-2 post OPU, all embryos could be frozen. Hopefully, in a near future, GnRHa triggering and vitrification of oocytes will become everyday practice. Only the combined use of a GnRH antagonist protocol with GnRHa triggering and subsequent single blastocyst transfer or embryo/oocyte freezing will completely abolish the risk of OHSS after ovarian hyperstimulation.
format Online
Article
Text
id pubmed-3230134
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32301342011-12-05 New algorithm for OHSS prevention Papanikolaou, Evangelos G Humaidan, Peter Polyzos, Nikos Kalantaridou, Sofia Kol, Sahar Benadiva, Claudio Tournaye, Herman Tarlatzis, Basil Reprod Biol Endocrinol Debate Ovarian hyperstimulation syndrome (OHSS) still remains a life-threatening complication of in vitro fertilization treatment (IVF), keeping patients and especially those, who previously experienced OHSS, from attempting infertility treatment and childbearing. The recent implementation of four new modalities: the GnRH antagonist protocol, GnRH agonist (GnRHa) triggering of ovulation, blastocyst transfer and embryo/oocyte vitrification, renders feasible the elimination of OHSS in connection with ovarian hyperstimulation for IVF treatment. The proposed current algorithm is based on the number of follicles developed after ovarian stimulation, setting a cut-off level at the development of 18 or more follicles. Further, fulfilling this criterion, the algorithm is based on four decision-making points: the final day of patient work-up, the day of triggering final oocyte maturation, day-1 post oocyte pick-up (OPU) and day-5 post OPU. If the physician decides to administer hCG for final oocyte maturation regardless the type of analogue used, he has the option on day-1 to either freeze all embryos or to proceed to day-5. On this day, based on the clinical condition of the patient, a decision should be made to either transfer a single blastocyst or to vitrify all blastocysts available. However, this strategy will not guarantee an OHSS free luteal phase especially if a pregnancy occurs. If the physician decides to trigger ovulation with GnRHa, feasible only with the antagonist protocol, embryos can be cultured until day-5. On this day a transfer can be performed with no risk of OHSS and spare blastocysts may be vitrified. Alternatively, on day-1 or day-2 post OPU, all embryos could be frozen. Hopefully, in a near future, GnRHa triggering and vitrification of oocytes will become everyday practice. Only the combined use of a GnRH antagonist protocol with GnRHa triggering and subsequent single blastocyst transfer or embryo/oocyte freezing will completely abolish the risk of OHSS after ovarian hyperstimulation. BioMed Central 2011-11-03 /pmc/articles/PMC3230134/ /pubmed/22054506 http://dx.doi.org/10.1186/1477-7827-9-147 Text en Copyright ©2011 Papanikolaou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Debate
Papanikolaou, Evangelos G
Humaidan, Peter
Polyzos, Nikos
Kalantaridou, Sofia
Kol, Sahar
Benadiva, Claudio
Tournaye, Herman
Tarlatzis, Basil
New algorithm for OHSS prevention
title New algorithm for OHSS prevention
title_full New algorithm for OHSS prevention
title_fullStr New algorithm for OHSS prevention
title_full_unstemmed New algorithm for OHSS prevention
title_short New algorithm for OHSS prevention
title_sort new algorithm for ohss prevention
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230134/
https://www.ncbi.nlm.nih.gov/pubmed/22054506
http://dx.doi.org/10.1186/1477-7827-9-147
work_keys_str_mv AT papanikolaouevangelosg newalgorithmforohssprevention
AT humaidanpeter newalgorithmforohssprevention
AT polyzosnikos newalgorithmforohssprevention
AT kalantaridousofia newalgorithmforohssprevention
AT kolsahar newalgorithmforohssprevention
AT benadivaclaudio newalgorithmforohssprevention
AT tournayeherman newalgorithmforohssprevention
AT tarlatzisbasil newalgorithmforohssprevention